Within Major Pharmaceutical Preparations industry Aldeyra Therapeutics Inc booked the highest Quick Ratio than Aldeyra Therapeutics Inc in the second quarter 2026. While total ranking remained the same in the Q2 2026 compared to the first quarter 2026 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents ALDX�s has?
What are ALDX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALDX Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-84.91 %	125.56 %	50.18 %	29.49 %	-15.68 %
Y / Y Cash & cash equivalent Change	-	-	-	-64.24 %	-17.49 %
Quick Ratio MRQ	-	-	-	0.72	1.75
ALDX's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	-80.61 %	-34.2 %	23.93 %	-4.54 %	189.74 %
Seq. Cash & cash equivalent Change	-	-	-	-60.77 %	2.45 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Aldeyra Therapeutics Inc 's Current Liabilities	$ 4 Millions	Visit ALDX's Balance sheet
Aldeyra Therapeutics Inc 's Cash & cash equivalent	$ 0 Millions	Visit ALDX's Balance sheet
Source of ALDX's Sales		Visit ALDX's Sales by Geography

Cumulative Aldeyra Therapeutics Inc 's Quick Ratio

ALDX's Quick Ratio for the trailling 12 Months

ALDX Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	6.86 %	28.14 %	-4.38 %	-18.99 %	-28.26 %
Y / Y Cash & cash equivalent TTM Growth	-90.7 %	-68.58 %	-43.69 %	14.86 %	114.95 %
Quick Ratio TTM	0.22	0.62	1.19	1.99	2.57
Total Ranking TTM	# 4149	# 4049	# 2255	# 3174	# 2918
Seq. Current Liabilities TTM Growth	-21.68 %	12.44 %	12.8 %	7.57 %	-6.08 %
Seq. Cash & cash equivalent TTM Growth	-71.83 %	-41.21 %	-32.61 %	-16.7 %	-4.78 %

Quick ratio ranking by company, industry and sector >> Back to ALDX Financial Strength Comparisons >> Go to Compare ALDX Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in ALDX's Current Liabilities to $3.51 millions, cumulative Quick Ratio to 0.22 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry ALDX achieved the highest Quick Ratio. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 4049 to 4149.

Explain Quick Ratio?
How much Cash & cash equivalents ALDX�s has?
What are ALDX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Within the Market	# 4149

trailing twelve months Quick Ratio Statistics
High	Average	Low
0	0	0

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry

Quick Ratio

Jun 30 2026 MRQ Cash & cash equivalent

Jun 30 2026 MRQ Current Liabilities

Date modified: 2026-09-26T07:21:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.